Venture-Ready Technologies are some of the University of Rochester’s most promising inventions. We believe the technologies and innovations described below have significant commercial potential. Some of these items could fit nicely into a company’s existing intellectual property portfolio to enhance a product line or help launch a new one. Others represent platform technologies that could constitute the foundation of a new startup company. In either case, we invite you to peruse the following which will be updated periodically with new featured patents. If anything is of interest, please contact UR Ventures.
A live-attenuated vaccine for canine influenza virus.
A digital optical cloak to hide an object from multiple viewpoints by digitally recreating a three-dimensional version of the background.
A novel vaccine against Type I Diabetes
A biomarker to save time and money in the treatment of arthritis.
A safe and effective therapy based on the bacterial AvrA peptide for the treatment of inflammatory bowel and celiac diseases.
A method to suppress premature stop codons in order to generate full-length mRNA using target-specific guide mRNAs.
A method of remyelinating axons using oligodendrocyte progenitor cells.
A novel method for treating and preventing dental diseases.
A novel synthetic lung surfactant for the treatment of neonatal and acute respiratory distress syndromes.
A novel method for treating and preventing fibrosis and fibrosis-related conditions using fibronectin binding proteins and polypeptides.
A novel therapy method for delivering localized anti-cancer responses without adverse body-wide side effects.
A novel therapy using light-activated chemokine receptors to direct specific lymphocytes to desired locations within a patient’s body.
A novel protocol to produce large quantities of nearly 100% homogenous heavy-labeled acyl-CoAs rapidly and inexpensively.
Small compounds that inhibit the uptake of amyloid-β into the brain.
A new cell therapy for treating damage to the central nervous system.
A treatment for hyperammonemic Encephalopathy and Seizures.
A safe and effective treatment for Rheumatoid Arthritis using approved drugs.
A simple and robust in vitro DNA-based diagnostic assay to aid in determining the prognosis of patients with chronic lymphocytic leukemia (CLL).
A safer and more effective nasal vaccine against influenza.
A novel strategy for developing safe and effective live-attenuated arenavirus vaccines.
Compounds that can induce melanin expression to aid in certain clinical indications or for cosmetic purposes.
Methods for the protection, repair, and regeneration of articular cartilage and fibrocartilaginous tissues using recombinant parathyroid hormones.
An RNA therapeutic approach based on a “tailor-made” mRNA splice factor to treat genetic diseases that are caused by mRNA splice site mutations, such as muscular dystrophy, β-thalassemia, retinitis pigmentosa, neurofibromatosis, and cancers.
A method of making hydrogen using semiconductor nanocrystals, an inexpensive catalyst, water, and sunlight.
A novel treatment for a variety of conditions resulting in female infertility.
A novel method for identifying patients at increased risk for a second (or subsequent) heart attack.
Novel polypeptides and immunogenic conjugates capable of inducing passive and active immunity against Pneumocystis carinii and Streptococcus pneumoniæ infections.
Novel methodologies to engineer an improved and more effective live attenuated flu vaccine.
A potential disease modifying treatment for inflammatory skin diseases using small molecule histamine 4 receptor inhibitors.
A novel peptide-based strategy for controlled transepithelial delivery of therapeutic molecules.
A novel approach to treat Type 2 diabetes.
A novel diagnostic test and therapeutic approach for neurodegenerative diseases, such as Alzheimer’s disease.
Small molecule anti-scarring agents that may inhibit myofibroblast formation at the site of surgical trauma.